Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer

Annals of Surgical Oncology

Volumn 7, Issue 2, 2000, Pages 133-138

  Belluco, Claudio ^a   Nitti, Donato ^a   Frantz, Marylin ^b   Toppan, Paola ^a   Basso, Daniela ^a   Plebani, Mario ^a   Lise, Mario ^a   Jessup, J Milburn ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

CEA; Colorectal carcinoma; Interleukin 6; Metastasis; Prognostic markers

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN 6; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; COLON CANCER; COLORECTAL CANCER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PROGNOSIS; RECTUM CANCER;

EID: 0034106055     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0133-7     Document Type: Article

References (38)

1. Gold P, Freeman SO. Demonstration of tumor specific antigen in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965;121:439-46.
2. Thomas P, Toth CA, Saini KS, Jessup JM, Steele GD. The structure, metabolism and function of the carcinoembryonic antigen gene family. Biochim Biophys Acta 1990;1032:177-89.
3. Chapman MA, Buckley D, Hensen DB, Armitage NC. Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer 1998;78:1346-9.
4. Harrison LE, Guillem JG, Paty P, Cohen AM. Preoperative carcinoembryonic antigen predicts outcomes in node-negative colon cancer patients: a multivariate analysis of 572 patients. J Am Coll Surg 1997;185:55-9.
5. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993;270:943-7.
6. Thompson JA. Molecular cloning and expression of carcinoembryonic antigen gene family members. Tumor Biol 1995;16:10-16.
7. Thomas P, Gangopadhyay A, Steele G, et al. The effect of transfection of the CEA gene on the metastatic behavior of the human colorectal cancer cell line MIP-101. Cancer Lett 1995;92:59-66.
8. Hashino J, Fukuda Y, Oikawa S, Nakazato H, Nakanishi T. Metastatic potential of human colorectal carcinoma SW1222 cells transfected with cDNA encoding carcinoembryonic antigen. Clin Exp Metastasis 1994;12:324-8.
9. Ishii S, Steele G, Ford R, et al. Normal colonic epithelium adheres to carcinoembryonic antigen and type IV collagen. Gastroenterology 1994;106:1242-50.
10. Jessup JM, Petrick AT, Toth CA, et al. Carcinoembryonic antigen: enhancement of liver colonisation through retention of human colorectal carcinoma cells. Br J Cancer 1993;67:464-70.
11. Gangopadhyay A, Bajenova O, Kelly TM, Thomas P. Carcinoembryonic antigen induces cytokine expression in Kupffer cells: implications for hepatic metastasis from colorectal cancer. Cancer Res 1996;56:4805-10.
12. Edmiston KH, Gangopadhyay A, Shoji Y, Nachman AP, Thomas P, Jessup JM. In vivo induction of murine cytokine production by carcinoembryonic antigen. Cancer Res 1997;57:4432-6.
13. Natali P, Nicotra MR, Cavaliere R, et al. Differential expression of intercellular adhesion molecule1 in primary and metastatic melanoma lesions. Cancer Res 1990;50:1271-8.
14. Tsujisaki M, Imai K, Hirata H, et al. Detection of circulating adhesion molecule-1 antigen in malignant disease. Clin Exp Immunol 1991;85-3-8.
15. Takada A, Ohmori K, Yoneda T, et al. Contribution of carbohydrate antigens sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993;53:354-61.
16. Liu Y, Tolbert EM, Sun AM, Dworkin LD. Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells. Am J Physiol 1996;27:F679-88.
17. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996;271:736-41.
18. Morson BC, Sobin LH. Histologic typing of intestinal tumours: WHO technical report. Geneva: World Health Organization, 1976.
19. LH Sobin, C Wittekind. UICC TNM Classification of Malignant Tumours. 5th ed. New York: Wiley-Liss, 1997.
20. Kaplan EL, Meier P. Non parametrics estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972;34:187-220.
22. Damas P, Ledoux D, Nys M, et al. Cytokine serum level during severe sepsis in human TL-6 as a marker of severity. Ann Surg 1992;215:356-62.
23. Roumen RMH, Hendriks T, Van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann Surg 1993;218:769-76.
24. Ohzato H, Yoshizaki K, Nishimoto N, et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992; 111:201-9.
25. Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL. Relationship of functional and antigenic interleukin-6 to disease activity in inflammatory bowel disease. Gastroenterology 1993; 104:1285-92.
26. Goydos JS, Brumfield AM, Frezza E, Booth A, Lotze MT, Carty SE. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma. Ann Surg 1998;3:398-404.
27. Dosquet C, Schaetz A, Faucher C, et al. Tumour necrosis factor-α, interleukin-1β and interleukin-6 in patients with renal cell carcinoma. Eur J Cancer 1994;30A:162-7.
28. Blay J-Y, Negrier S, Combaret V, et al. Serum level of interleukin-6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 1992;52:3317-22.
29. Stadler WM, Richards JM, Voglezang NJ, et al. Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator. J Natl Cancer Inst 1992;23:1835-6.
30. Mouawad R, Benhammouda A, Rixe O, et al. Endogenous interleukin 6 levels in patients with metastatic malignant melanoma: correlation with tumor burden. Clin Cancer Res 1996;2:1405-9.
31. Gallo O, Gori AM, Attanasio M, Martini F, Fini-Storchi O, Abbate R. Interleukin-6 serum level and monocyte production in head and neck cancer. Br J Cancer 1992;65:479-80.
32. Plante M, Rubin SC, Wong GY. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer 1994;73:1882-8.
33. Fayad L, Cabanillas F, Talpaz M, McLaughlin P, Kurzrock R. High serum interleukin-6 levels correlate with a shorter failure-free survival in indolent lymphoma. Leuk Lymphoma 1998;30:563-71.
34. Seymour JF, Talpaz M, Hagemeister FB, Cabanillas F, Kurzrock R. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease. Am J Med 1997;102: 21-8.
35. Ueda T, Shimada E, Urakawa T. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol 1994;29:423-9.
36. Oka M, Yamamoto K, Takahashi M, et al. Relationship between serum levels of interleukin 6, various disease parameters, and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 1996;56:2776-80.
37. Wu CW, Wang SR, Chao MF, et al. Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 1996; 91:1417-22.
38. Piancatelli D, Romano P, Sebastiani P, Adorno D, Casciani CU. Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunother 1999;22:25-32.